scispace - formally typeset
C

Christophe Combadière

Researcher at University of Paris

Publications -  165
Citations -  13471

Christophe Combadière is an academic researcher from University of Paris. The author has contributed to research in topics: Chemokine & Chemokine receptor. The author has an hindex of 57, co-authored 160 publications receiving 12153 citations. Previous affiliations of Christophe Combadière include National Institutes of Health & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

TL;DR: It is shown that chemokine-mediated signals critically determine the frequency of monocytes in the blood and bone marrow under both noninflammatory and atherosclerotic conditions and that CCL2, CX3CR1, and CCR5 play independent and additive roles in atherogenesis.
Journal ArticleDOI

Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout Mice

TL;DR: The CX3CR1-CX3CL1 pathway seems to play a direct and critical role in monocyte recruitment and atherosclerotic lesion development in a mouse model of human atherosclerosis.
Journal ArticleDOI

Molecular Cloning of Human Eotaxin, an Eosinophil-selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3

TL;DR: It is shown that human eotaxin is a potent and highly specific agonist for CC chemokine receptor 3, a G protein-coupled receptor selectively expressed in human eosinophils, and may be good targets for the development of selective drugs for inflammatory diseases where eos inophils contribute to pathogenesis, such as asthma.